| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000024658 |
| Receipt No. | R000028366 |
| Official scientific title of the study | Nursing research on pain associated with subcutaneous Treprostinil Therapy in patients with pulmonary arterial hypertension |
| Date of disclosure of the study information | 2016/11/01 |
| Last modified on | 2016/10/31 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Nursing research on pain associated with subcutaneous Treprostinil Therapy in patients with pulmonary arterial hypertension | |
| Title of the study (Brief title) | Nursing research on pain associated with subcutaneous Treprostinil Therapy in patients with pulmonary arterial hypertension | |
| Region |
|
|
| Condition | ||
| Condition | pulmonary arterial hypertension | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Clarify the problems of nursing care in pain management to the Cardiology definitive Treprostinil continuous subcutaneous administration patient. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | pain |
| Key secondary outcomes | |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who had done Treprostinil continuous subcutaneous administration from October 2015 until June 2016. | |||
| Key exclusion criteria | Not set for the case study. | |||
| Target sample size | 2 | |||
| Research contact person | |
| Name of lead principal investigator | Chie Myouchin |
| Organization | hospital |
| Division name | West 9 floor |
| Address | 1-1 Seryoutyou Aoba-ku Sedai-shi Miyagi-ken 8574-980 |
| TEL | 022-717-7786 |
| dbfhw551@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Chie Myouchin |
| Organization | Tohoku University |
| Division name | West 9 Floor |
| Address | 1-1 Seryoutyou Aoba-ku Sedai-shi Miyagi-ken 8574-980 |
| TEL | 022-7171-7786 |
| Homepage URL | |
| dbfhw551@yahoo.co.jp | |
| Sponsor | |
| Institute | Tohoku University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tohoku University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | In the west 9 floor ward researchers belong, to target the two patients who started the Trepurostinil continuous subcutaneous administration to pulmonary hypertension. Symptoms from the October 2015 first case of the subject was admitted to the second example in June 2016 by the subject was discharged of, about the contents of the implementation nursing intervention, information collected from nursing records and medical records. Lack of information to supplement with your recorder. Further, based on the data obtained from nursing records and medical records, summarized in chronological nursing interventions |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028366 |